Clinical Trial

Construct Validity and Responsiveness of EQ-5D-3L and EQ-5D-5L in Patients With Inflammatory Joint Disease

Name: Construct Validity and Responsiveness of EQ-5D-3L and EQ-5D-5L in Patients With Inflammatory Joint Disease — clinical trial record (NCT07580092)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

The aim of this study is to compare the construct validity (convergent validity and known-groups validity) and responsiveness of EQ-5D-3L and EQ-5D-5L in patients with inflammatory joint disease. The study is based on prospectively collected data through the Swedish Rheumatology Quality Register (SRQ).

Trial Details

NCT Number	NCT07580092
Lead Sponsor	Karolinska Institutet Collaborators: Karolinska University Hospital, The EuroQol Research Foundation
Conditions	Ankylosing Spondylitis, Rheumatoid Arthritis (RA), Psoriatic Arthritis, Polyarthritis, Inflammatory Joint Disease (IJD)
Enrollment	6,967 participants
Start Date	2023-11-30
Primary Completion	2026-03-05 (estimated)
Study Completion	2026-03-05 (estimated)
Updated on ClinicalTrials.gov	2026-05-12